Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden · Delayed Price · Currency is SEK 2.040
0.00 (0.00%)
Jul 6, 2026, 5:29 PM CET
STO:NEWBRY Market Cap
STO:NEWBRY has a market cap or net worth of 62.01 million as of July 6, 2026. Its market cap has decreased by -10.86% in one year.
Market Cap
62.01M
Enterprise Value
51.94M
Revenue
32.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.04
Market Cap Chart
Since February 4, 2022, STO:NEWBRY's market cap has decreased from 245.97M to 62.01M, a decrease of -74.79%. That is a compound annual growth rate of -26.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 62.01M | 77.39% |
| Dec 30, 2025 | 34.96M | -59.06% |
| Dec 30, 2024 | 85.39M | 42.48% |
| Dec 29, 2023 | 59.93M | -56.08% |
| Dec 30, 2022 | 136.45M | -44.52% |
| Feb 4, 2022 | 245.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orexo AB | 848.60M |
| Dicot Pharma AB | 783.92M |
| EQL Pharma AB | 683.61M |
| Nanexa AB | 662.46M |
| Enzymatica AB | 568.00M |
| Cinclus Pharma Holding AB | 510.05M |
| Moberg Pharma AB | 444.16M |
| Klaria Pharma Holding AB (publ.) | 190.63M |